Bonomo R, Canta A, Chiorazzi A, Carozzi VA, Meregalli C, Pozzi E, Alberti P, Frampas CF, Van der Veen DR, Marmiroli P, Skene DJ, Cavaletti G. Effect of age on metabolomic changes in a model of paclitaxel-induced peripheral neurotoxicity. J
Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry
Iaffaldano P, Lucisano G, Guerra T, Patti F, Cocco E, De Luca G, Brescia Morra V, Pozzilli C, Zaffaroni M, Ferraro D, Gasperini C, Salemi G, Bergamaschi R, Lus G, Inglese M, Romano S, Bellantonio P, Di Monte E, Maniscalco
Vacuolar Proton-Translocating ATPase May Take Part in the Drug Resistance Phenotype of Glioma Stem Cells
Giambra M, Di Cristofori A, Raimondo F, Rigolio R, Conconi D, Chiarello G, Tabano SM, Antolini L, Nicolini G, Bua M, Ferlito D, Carrabba G, Giussani CG, Lavitrano M, Bentivegna A. Vacuolar Proton-Translocating ATPase May Take Part in the Drug
Other platforms
Flow cytometry RT-PCR mice/rats blood chemistry and hematology computerized morphometry innovative treatments: Use of Synchrotron Radiation to enhance anticancer drugs effectiveness
Clinical studies
At the Dept. of Neurology, “FONDAZIONE IRCCS SAN GERARDO DEI TINTORI” Hospital, Monza: Neuroimmunology CenterCancer-Neurology Outpatients CenterNeurophysiology Unit
Nanolive
Nanolive’s technology de-risks the biopharma investments into in-vivo studies by providing a game changing label-free new access to living cells. Our data rich analysis offers new scientific insights that would be missed with simple endpoint or fluorescence-based assays. A revolutionary non-invasive live
Peripheral neuropathies: scientist from ENU among the best 40 researchers under 40
Paola Alberti, researcher and neurologist of the ENU team, entered the rankings “CMTA’s 40 Under 40“, that brings together the best 40 researchers under 40 who are making a fundamental contribution to research on Charcot-Marie-Tooth (CMT),a form of hereditary peripheral
Neurodegeneration: can metabolites from Eremurus persicus help?
Cavalloro V, Marchesi N, Linciano P, Rossi D, Campagnoli LIM, Fossati A, Ahmed KM, Malacrida A, Miloso M, Mazzeo G, Abbate S, Longhi G, Ambrosio FA, Costa G, Alcaro S, Pascale A, Martino E, Collina S. Neurodegeneration: can metabolites from Eremurus
Project funded by Cariplo Foundation
One of ENU members, Paola Alberti, MD, PhD, was recently funded by Fondazione Cariplo under the call Ricerca Biomedica condotta da Giovani Ricercatori (i.e., Biomedical Research conducted by Young Investigators). She was assigned a 250,000 euros grant as PI to conduct a 3 year project
Grant by Fondazione Giovanni Celeghin ONLUS
Synthesize new molecules capable of reducing the invasiveness of glioblastoma (the most aggressive of brain tumors) and counteracting the phenomena of drug resistance to the chemotherapy currently in use. This is the goal pursued by a multidisciplinary and inter-university research